Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

UVB exposure affects retinoid metabolism, which is important for skin cancer progression and treatment.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Inhibiting ODC can prevent UV-induced skin cancer.

Bald-headed individuals may need early non-invasive detection for skin changes linked to cancer risk.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Certain drugs that block specific enzymes can help treat prostate diseases.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Disrupting Bcl-xL in mice reduces skin cancer risk.

Skin and hair can help us understand organ regeneration, especially how certain stem cells might be used to form new organs.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

A new method accurately measures a drug in skin for cancer therapy research.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

Analog 23 is a promising compound for prostate cancer treatment.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.